HALEOS LABS
Back to Income Statement
|
HALEOS LABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹345 Cr | ₹306 Cr | ₹316 Cr | ₹350 Cr | ₹266 Cr |
What is the latest Revenue of HALEOS LABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹345 Cr |
| Mar2024 | ₹306 Cr |
| Mar2023 | ₹316 Cr |
| Mar2022 | ₹350 Cr |
| Mar2021 | ₹266 Cr |
How is Revenue of HALEOS LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹345 Cr | 12.67 | |
| Mar2024 | ₹306 Cr | -3.04 | |
| Mar2023 | ₹316 Cr | -9.86 | |
| Mar2022 | ₹350 Cr | 31.81 | |
| Mar2021 | ₹266 Cr | - | |
Compare Revenue of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹494.1 Cr | -1% | 21.9% | 8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | -1% |
21.9% |
8.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses